CorMedix

CRMD

ATLANTA, GA – – (Globe Newswire – March 25, 2025) – – Holzer & Holzer, LLC is investigating whether CorMedix Inc. (“CorMedix” or the “Company”) (NASDAQ: CRMD) complied with federal securities laws. On March 25, 2025, Cormedix reported fourth quarter and full year 2024 financial results. During the Company’s earnings call held the same day, Cormedix noted that “we do expect to begin to see some net price erosion beginning in the second quarter of 2025.” Following this news, the price of the Company’s stock dropped.

If you purchased CorMedix stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/cormedix/ to discuss your legal rights.

Registration Deadline

Lead Plaintiff Deadline Has Passed

Submit Your Information
Submit Your Form

Submit Your Information

Name(Required)
Address
Shares Purchased(Required)
Date of Shares Purchased
Number of Shares Acquired
Acquisition Price Per Share
 
Shares Sold
Date of Shares Sold
Number of Shares Sold
Selling Price Per Share
 
By clicking on the button below, I am requesting Holzer & Holzer, LLC send me documents necessary to retain the firm.